See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

David Raben profile image

David Raben

CMO, Bicara Therapeutics at Bicara Therapeutics
Intro Book
David Raben, a seasoned oncology professional with 22 years of experience, holds a Doctor of Medicine degree and has authored over 180 publications, serving as a professor and associate member of the University of Colorado Cancer Center.
  • Claim this Profile
Location
Englewood, Colorado, United States, US
image
image

Refer a Friend to Get
100 Credits For FREE

Refer a Friend Now

Bio

Generated by
Topline AI
David Raben is a seasoned executive with over 25 years of experience in the life sciences industry, most recently serving as CMO at Bicara Therapeutics. Prior to this, he held key leadership positions at Amgen and Genentech, where he drove late-stage oncology development and oversaw research collaborations. A renowned expert in radiation oncology, Dr. Raben has spent over 20 years as a professor and associate member of the University of Colorado Cancer Center, publishing extensively in top-tier journals and serving on national committees for the American Head and Neck Society and NRG Oncology.

Experience

  • Bicara Therapeutics
    • Cambridge, Massachusetts, United States
    • CMO, Bicara Therapeutics
      • Jul 2023 - Present
      • Cambridge, Massachusetts, United States

  • Amgen
    • VP, Late Stage Oncology Development
      • Nov 2021 - Jul 2023

  • Genentech
    • San Francisco Bay Area
    • VP, Late Stage Development, PDO
      • Sep 2019 - Jun 2022
      • San Francisco Bay Area

  • University of Colorado Anschutz Medical Campus
    • Aurora, Colorado, United States
    • Professor, Radiation Oncology
      • May 1998 - Sep 2020
      • Aurora, Colorado, United States

      Dr. Raben has spent more than 20 years as a professor and an associate member of the University of Colorado Cancer Center, where his main areas of focus have been evaluating and combining novel biologic therapies in the laboratory and in clinical trials for patients with locally advanced cancers of the head and neck and lung. His extensive clinical expertise in the management of head and neck and thoracic cancers also extends to genitourinary cancers, along with translational experience in areas such as EGFR signaling, DNA damage repair, TGFb and checkpoint inhibition.Nationally, Dr. Raben served on the NRG Oncology Head and Neck Cancer (HNC) steering committee for over 15 years and established and led the Radiation Developmental Therapeutics Committee at the NRG. He remains an active member of the American Head and Neck Society, IASLC, ESMO, AACR and ASTRO. Dr. Raben has authored over 180 publications, 13 book chapters and his research is published in high impact journals including the New England Journal of Medicine, Clinical Cancer Research, Nature Medicine, and Nature Biology Communications.

Education

  • Duke University
    Bachelor of Arts - BA, Pschychology
  • The Johns Hopkins University School of Medicine
    Radiation Oncology Residency Program
  • Wake Forest University School of Medicine
    Doctor of Medicine - MD

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Pharmaceutical and Healthcare”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles